Lv31
290 积分 2021-07-09 加入
Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia
2小时前
待确认
Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer
1个月前
已完结
Leptomeningeal Carcinomatosis
10个月前
已完结
CD44 lung cancer stem cell-derived pericyte-like cells cause brain metastases through GPR124-enhanced trans-endothelial migration
1年前
已完结
Adebrelimab (SHR-1316) in combination with chemotherapy as perioperative treatment in patients with resectable stage II-III NSCLC: an open-label, multicenter, phase 1b trial
1年前
已完结
Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-Mutated Advanced NSCLC
2年前
已完结
Rational, biologically based treatment of EGFR -mutant non-small-cell lung cancer
2年前
已完结
EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment
3年前
已完结
Glutathione peroxidase 4-dependent glutathione high-consumption drives acquired platinum chemoresistance in lung cancer-derived brain metastasis
3年前
已关闭
Immune-checkpoint inhibitor-associated diabetes compared to other diabetes types - a prospective, matched control study
3年前
已完结
皖公网安备34019202002308
